COVID-19 treatment

Physicians from all specialties across Vanderbilt University Medical Center are volunteering their time to communicate daily with family members of patients in the COVID-19 Intensive Care Unit.

Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.

Against the noisy background of masking debates, surges, flattening curves, warp speed initiatives, conflicting messages and misinformation, political controversies, not to mention a revolutionary mRNA technology, millions of people are deciding whether to take the COVID-19 vaccine.

Vanderbilt University Medical Center has a new weapon in the fight against COVID-19 — an investigational antibody treatment approved last month for emergency use in COVID-19 outpatients at high risk of developing severe disease or requiring hospital care.

Vanderbilt LifeFlight has transported more than 220 Covid-19 patients since the pandemic started with the numbers rising dramatically in the last few weeks.

James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award.

In the midst of a long, hard trek, we are inclined to focus on the miles remaining — forgetting all the terrain we’ve already conquered. Taking a few moments to reflect on where we started and how far we’ve come can replenish resilience, restoring vital energy to keep moving.